You are here: Home Divisions Chemical Biology and Medicinal Chemistry CBMC Seminars

CBMC Seminars

MEDC 899 Spring 2013 Schedule

Joint Seminars in CBMC and Bioorganic Chemistry

Wednesdays, 12:00–1:30 p.m., Beard Hall, Room 116 unless otherwise noted

Date

Speaker

Title

January 9

Stephen Miller, PhD
(University of Massachusetts)

Building Better Luciferins and Fluorophores for Live Cell Imaging

January 16

Luong Nguyen

Expanding Deep Quench Protein Kinase Assay and A New Way of Light-Induced Control Molecular Activity

January 23

Paul Thompson, PhD
(The Scripps Research Institute)

Chemical Probes for the Protein Arginine Deiminases: Therapeutic Targets for Inflammatory Disease and Cancer

January 30

Kyle Konze

Activation of AMPK via Small Molecule Antagonism of Nur77: Implications for Diabetic Intervention (Literature)

February 6

Stephen Martin, PhD
(University of Texas at Austin)

Correlating Structure and Energetics in Protein-Ligand Interactions: Paradigms and Paradoxes

February 13

Chuan He, PhD
(University of Chicago)

Reversible Epigenetic Methylation of DNA and RNA

February 20

Jake Stuckey

Divergent Allosteric Control of the IRE1α Endoribonuclease Using Kinase Inhibitors (Literature)

February 27

Todd Yeates, PhD
(University of California, Los Angeles)
11:00 a.m., Bioinformatics Bldg. 1131

Natural and Engineered Protein Cages: Structure, Function, and Frameworks for Synthetic Biology

March 6

Aravinda de Silva, PhD
(UNC School of Medicine)

Human Antibodies as Doubled-Edged Swords in Dengue Virus Infections

March 20

Rebecca Page, PhD
(Brown University)

MasQueRAde: A Novel Toxin: Antitoxin System that Regulates Persistence and Antibiotic Resistance in E. coli

March 27

Yingqiu Zhou

Development of Domain-Specific Antibody Inhibitors against Amyloid Fibril Assembly (Literature)

April 3

Carrow Wells

Antibody Recruiting Small Molecules (Literature)

April 10

Andrew Hopkins (University of Dundee, UK)

Polypharmacology in drug design

April 17

Nate Oien

Assay Development to Monitor Real Time Activity of Endogenous Erythrocyte Proteins

April 24

Brian Blagg, PhD
(University of Kansas)

Hsp90 Inhibitors: Past, Present and Future

May 8

Charles Deber, PhD
(University of Toronto)

Development of cationic antimicrobial peptides against bacterial biofilms

Document Actions